Construction,Expression and Function of Recombinant Plasmid Expressing Human Hepatocyte Growth Factor Activator

Feng XUE,Xueming ZHOU,Longmei XU,Cheng ZHANG,Wei DENG,Yun XIA,Jianjun ZHANG,Qiang XIA

DOI: https://doi.org/10.3969/j.issn.1008-7125.2010.01.004

2010-01-01

Abstract:Background: Hepatocyte growth factor activator (HGFA) is the major protease that cleaves inactive single-chain HGF (pro-HGF) to its active form, and plays an important role in reparation and regeneration of injured tissue or organ. Aims: To construct the rhHGFA-Fc fusion protein and to confirm its hepatocyte protective effect. Methods: The vector expressing fusion protein of humanized HGFA active fragment and IgG Fc fragment was constructed by gene recombination, and then transfected into human embryonic kidney 293 cells by Lipofectamine 2000. The expression product of 293 cells was purified. The purified product (rhHGFA-Fc fusion protein) and its enzyme activity on pro-HGF was identified by Western blotting, its effect on mediating the inhibition of hepatocyte apoptosis was determined by flow cytometry. Results: The purified product of 293 cells transfected with the recombinant plasmid formed a lane at the position of 62 kDa with SDS-PAGE and had a specific reaction with monoclonal antibody against hHGFA by Western blotting. rhHGFA-Fc fusion protein could cleave pro-HGF into α chain and β chain, the enzyme activity was dose-dependent and the IC50 was 8.22 nmol/L. The flow cytometry results indicated that the fusion protein could inhibit the apoptosis of hepatocyte by activating the pro-HGF. Conclusions: The rhHGFA-Fc fusion protein expressed by 293 cells has high purity and enzyme activity, and can convert pro-HGF to its active form adequately. It might be a potential drug for severe liver injury especially the cirrhosis.